PXRB (PixarBio) Shares Buyback Ratio % : 0.00 (As of Sep. 21, 2024)

View and export this data going back to 2016. Start your Free Trial

What is PixarBio Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. PixarBio's current shares buyback ratio was 0.00%.

PixarBio Shares Buyback Ratio % Historical Data

The historical data trend for PixarBio's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio Shares Buyback Ratio % Chart

PixarBio Annual Data

Trend

Dec14

Dec15

Shares Buyback Ratio %

97.68

PixarBio Quarterly Data
	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16
Shares Buyback Ratio %	Get a 7-Day Free Trial					-	-	-4,740.71	-	97.93

PixarBio Shares Buyback Ratio % Calculation

PixarBio's Shares Buyback Ratio for the fiscal year that ended in Dec. 2015 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2014 )	-	Shares Outstanding (EOP) (A: Dec. 2015 ))	/	Shares Outstanding (EOP) (A: Dec. 2014 )
	=	(2229.458	-	51.68)	/	2229.458
	=	97.68%

PixarBio's Shares Buyback Ratio for the quarter that ended in Sep. 2016 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2016 )	-	Shares Outstanding (EOP) (A: Sep. 2016 ))	/	Shares Outstanding (EOP) (A: Jun. 2016 )
	=	(2501.68	-	51.68)	/	2501.68
	=	97.93%

PixarBio Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of PixarBio's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

PixarBio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155

Website

https://www.pixarbio.com

PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.